发明名称 2-AMINOPYRIDINE DERIVATIVES USEFUL AS KINASE INHIBITORS
摘要 Disclosed are (2-aminopyridin-3-yl)(heteroaryl)methanone derivatives as represented by the general formula, wherein B is a monocyclic heteroaromatic ring, a 6,6 bicyclic heteroaromatic ring, or a 6,5 bicyclic heteroaromatic ring wherein B is optionally and independently substituted with R12' and independently optionally and independently substituted with one or more R12 groups in addition to R3; Z is O or S; R1 is hydrogen, halogen, cyano, nitro, or -T1-Q1; R2 is hydrogen, halogen, cyano, nitro or optionally and independently substituted alkyl; R3 is halogen, cyano, nitro, or -T2-Q2; and wherein the remaining substituents are as defined herein. Further disclosed is a composition which comprises a compound of pharmaceutically acceptable salt thereof as defined above, and a pharmaceutically acceptable carrier, adjuvant, or vehicle for treating or preventing a protein kinase-mediated condition and particularly a GSK 3 mediated condition such as diabetes, Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS-associated dementia, bipolar disorder, amyotrophic lateral sclerosis, multiple sclerosis, schizophrenia, leukocytopenia, cardiomyocyte hypertrophy, stroke, and rheumatoid arthritis.
申请公布号 NZ578744(A) 申请公布日期 2012.02.24
申请号 NZ20080578744 申请日期 2008.01.30
申请人 VERTEX PHARMACEUTICALS INCORPORATED 发明人 JIMENEZ, JUAN-MIGUEL;BEMIS, GUY;MALTAIS, FRANCOIS;WANG, TIANSHENG;KNEGTEL, RONALD;DAVIS, CHRIS;FRAYSSE, DAMIEN;BOYALL, DEAN;SETTIMO, LUCA;YOUNG, STEPHEN;MORTIMORE, MICHAEL
分类号 C07D213/73;A61K31/444;A61P25/00;A61P35/00;C07D401/14;C07D409/06;C07D417/06;C07D487/04 主分类号 C07D213/73
代理机构 代理人
主权项
地址